Author:
Klavž Janez,Gorenjak Maksimiljan,Marinšek Martin
Subject
Pathology and Forensic Medicine,Law
Reference19 articles.
1. EMCDDA European Drug Report 2015: Trends and Developments, Euro Surveill, doi: 0.2810/084165, Available from 〈http://www.emcdda.europa.eu/〉.
2. New designer drugs (synthetic cannabinoids and synthetic cathinones): review of literature;Cottencin;Curr. Pharm. Des.,2014
3. Identification and quantification of metabolites of AB-CHMINACA in a urine specimen of an abuser;Wurita;Leg. Med.,2015
4. New cannabimimetic indazole derivatives, N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB-PINACA) and N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (AB-FUBINACA) identified as designer drugs in illegal products
5. Pharmacology of indole and indazole synthetic cannabinoid designer drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA;Banister;ACS Chem. Neurosci.,2015
Cited by
45 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献